NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/07/2025
Voltar para busca
Dado oficial do USPTO
LEAPFROG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
26/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
06/07/2022
Data de registro
16/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/04/2024
Última transação
26/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
CORNWELL, ANDREA
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Leapfrog Remedies Ltd
Representantes
Miriam D. Trudell Davis Graham & Stubbs LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals for the prevention and treatment of iron disordersallergiesskin disordersimmune system related diseases and disorders; Pharmaceuticals preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalherpetologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders in domestic animals; Antibacterial preparations for human absorption and consumptionantibacterial pharmaceuticalsantibacterial sprayantibacterial substance for medical purposesantibacterial hand lotions; antibiotic preparations; antiviral and anti-infectious preparationsantiviralspharmaceutical products for the treatment of infectious diseases or viral infections; anti-inflammatory preparations; pharmaceutical preparations for dermatological uses; medicinal preparations for slimming purposes; antisepticsdisinfectants; diagnostic preparations for medical purposes; natural remedies in the nature of preparations for the treatment of gastrointestinal conditionshormonal and chemical imbalanceimmune system related diseases and disorderssleep disorders; herbal tinctures for medical purposes; herbal health preparations and remediesherbal supplementsremedies in the form of chewable tabletsfor boosting energyboosting immune systempromoting healthy skin; cough remediescough syrupscough lozengescough treatment preparations; remedies for coldspreparations for treating colds; pharmaceutical preparations derived from natural substances for remedial purposesfor treating viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalherpetologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; nasal sprays for medical purposesnasal rinsenasal drops for treatment of allergiesnasal decongestants; allopathic remediespharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; homeopathic remedieshomeopathic supplementshomeopathic pharmaceuticals for use in the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenito-urinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; herbal tea preparations for medicinal use; herbal oils being herbal extracts adapted for medical useherbs for medicinal uses; roots for medicinal purposes; peels for medicinal purposes in the nature of medicated skin care preparations; medicated hair lotions and shampoos; medicated skin care lotions and creams; dietary and nutritional supplements for human beings; mineral nutritional supplements; vitamin supplements; dietetic substancespreparationschewstablets adapted for medical use; food for babies and infants; infant formula; dietary fibre for treating constipationaiding digestion; protein powder dietary supplements; medical plasters
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/11/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
15/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/11/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/10/2024
FIMP
FINAL DISPOSITION PROCESSED
19/10/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
16/04/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/03/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
30/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/01/2024
PUBO
PUBLISHED FOR OPPOSITION
30/01/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/01/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2023
RFNT
REFUSAL PROCESSED BY IB
04/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/06/2023
RFRR
REFUSAL PROCESSED BY MPU
09/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/04/2023
CNRT
NON-FINAL ACTION WRITTEN
25/04/2023
DOCK
ASSIGNED TO EXAMINER
20/04/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/10/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
27/10/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/10/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LEAPFROG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.